Maj Westman

发表

Low prevalence of transmitted drug resistance among newly diagnosed HIV‐1 patients in Latvia

J. Albert, B. Rozentāle, D. Balode, 2010, Journal of medical virology.

Biomarkers in tissue from patients with upper gastrointestinal cancers treated with erlotinib and bevacizumab

B. Skov, I. Christensen, H. Pappot, 2011, Cancer biology & therapy.

IDH1 and IDH2 mutations in therapy-related myelodysplastic syndrome and acute myeloid leukemia are associated with a normal karyotype and with der(1;7)(q10;p10)

M. Andersen, J. Pedersen‐Bjergaard, M. Andersen, 2013, Leukemia.

TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy.

J. W. Hansen, P. Guldberg, K. Grønbæk, 2017, Blood.

LYMPHOID NEOPLASIA TP53 mutations identify younger mantle cell lymphoma patients who do not bene ﬁ t from intensive chemoimmunotherapy

J. W. Hansen, P. Guldberg, K. Grønbæk, 2017 .

Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations

L. Kristensen, Helene Myrtue Nielsen, L. Hansen, 2017, Scientific Reports.

A Highly Sensitive Quantitative Real-Time PCR Assay for Determination of Mutant JAK2 Exon 12 Allele Burden

H. Hasselbalch, E. Høgdall, L. Kjær, 2012, PloS one.

Mutations in idiopathic cytopenia of undetermined significance assist diagnostics and correlate to dysplastic changes

J. W. Hansen, L. Kristensen, L. Saft, 2016, American journal of hematology.